Clonal spread of Mycobacterium monacense strains among patients with extrapulmonary mycobacteriosis
Mycobacterium monacense in extrapulmonary cultures accentuates the need for improved diagnostics and enhanced clinical awareness of infections with rare NTM. WGS highlights the potential significance provided by plasmid-encoded genes. Current treatment regimens for MTBC exhibit therapeutic efficacy against Mycobacterium monacense isolates.
Authors
- Giovanni Ghielmetti (ORCID: https://orcid.org/0000-0002-3936-9687)
- Robin M. Warren (ORCID: https://orcid.org/0000-0001-5741-7358)
- Christoffel J. Opperman (ORCID: https://orcid.org/0000-0002-6676-5431)
- C P Spies (ORCID: https://orcid.org/0009-0009-9580-8777)
- Wynand J. Goosen (ORCID: https://orcid.org/0000-0001-6614-9084)
- Yonas Ghebrekristos (ORCID: https://orcid.org/0000-0003-2002-5240)
- Michael Biggel (ORCID: https://orcid.org/0000-0002-1337-2132)
- Sarishna Singh (ORCID: https://orcid.org/0000-0002-1794-4126)
- Aysha Ahmed (ORCID: https://orcid.org/0009-0004-1014-5104)
- Marianna de Kock (ORCID: https://orcid.org/0009-0000-4708-4537)
- Tristen Lourens (ORCID: https://orcid.org/0000-0001-8005-062X)
Institutions
- National Health Laboratory Service (ZA)
- University of Cape Town (ZA)
- University of Zurich (CH)
- Stellenbosch University (ZA)
- University of the Free State (ZA)
- City of Cape Town (ZA)
Publication Details
- Journal
- European Journal of Clinical Microbiology & Infectious Diseases
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1007/s10096-025-05318-y
- Primary Topic
- Mycobacterium research and diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Health Laboratory Service